Identification of "latent hits" in compound screening collections

Journal of Medicinal Chemistry

Volumn 46, Issue 16, 2003, Pages 3441-3444

  Mestres, Jordi ^a   Veeneman, Gerrit H ^b  

^a MERCK RESEARCH LABORATORIES   (United States)

^b NV ORGANON   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DIANISYLHEXENE; DIETHYLSTILBESTROL; DIETHYLSTILBESTROL DERIVATIVE; DIETHYLSTILBESTROL METHYL ETHER; ESTRADIOL; ESTRADIOL DERIVATIVE; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; PROGESTERONE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CHEMICAL MODIFICATION; CHO CELL; CONTROLLED STUDY; CRYSTAL STRUCTURE; DRUG ACTIVITY; DRUG IDENTIFICATION; DRUG RECEPTOR BINDING; DRUG SCREENING; DRUG STRUCTURE; DRUG TARGETING; FEMALE; MEDICAL TECHNOLOGY; NONHUMAN; PHARMACOPHORE; STRUCTURE ACTIVITY RELATION; TRANSACTIVATION;

ANIMALS; CHO CELLS; CRICETINAE; CRYSTALLOGRAPHY, X-RAY; DATABASES, FACTUAL; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; HUMANS; LIGANDS; MODELS, MOLECULAR; RATS; RECEPTORS, ESTROGEN; STRUCTURE-ACTIVITY RELATIONSHIP; TRANS-ACTIVATION (GENETICS);

EID: 0041342061     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm034078c     Document Type: Article

References (25)

1. Lahana, R. How Many Leads from HTS? Drug Discovery Today 1999, 4, 447-448.
2. Hann, M.; Leach, A. R.; Harper, G. Molecular Complexity and Its Impact on the Probability of Finding Leads for Drug Discovery. J. Chem. Inf. Comput. Sci. 2001, 41, 856-864.
3. Martin, Y. C.; Kofron, J. L.; Traphagen, L. M. Do Structurally Similar Molecules Have Similar Biological Activity? J. Med. Chem. 2002, 45, 4350-4358.
4. Johnson, M. A., Maggiora, G. M., Eds. Concepts and Applications of Molecular Similarity; Wiley: New York, 1990.
5. Akamanchi, K. G.; Varalakshmy, N. R. Aluminium Isopropoxide-TFA, a Modified Catalyst for Highly Accelerated Meerwein-Ponndorf-Verley (MPV) Reduction. Tetrahedron Lett. 1995, 36, 3571-3572.
6. Node, M.; Kumar, K.; Nishide, K.; Ohsugi, S.; Miyamoto, T. Odorless Substitutes for Foul-Smelling Thiols: Synthesis and Applications. Tetrahedron Lett. 2001, 42, 9207-9210.
7. Shi, L. M.; Fang, H.; Tong, W.; Wu, J.; Perkins, R.; Blair, R. M.; Branham, W. S.; Dial, S. L.; Moland, C. L.; Sheehan, D. M. QSAR Models Using a Large Diverse Set of Estrogens. J. Chem. Inf. Comput. Sci. 2001, 41, 186-195.
8. Despite the wealth of structural information on the estrogen receptor from X-ray crystallography, note that docking methods are not well suited for identifying latent hits because these compounds are heavily penalized by scoring functions because of the lack of the key functionalities for interacting with the receptor cavity.
9. Merck. German Patent NL 6600810, 1965.
10. Saednya, A.; Hart, H. Two Efficient Routes to m-Terphenyls from 1,3-Dichlorobenzenes. Synthesis 1996, 1455-1458.
11. Pike, A. C. W.; Brzozowkki, A. M.; Hubbard, R. E.; Bonn, T.; Thorsell, A.-G.; Engström, O.; Ljungren, J.; Gustafsson, J.-A.; Carlquist, M. Structure of the Ligand-Binding Domain of Oestrogen Receptor Beta in the Presence of a Partial Agonist and a Full Antagonist. EMBO J. 1999, 18, 4608-4618.
12. Eichenauer, U. BasF A.G. German Patent DE3831712, 1990.
13. Yamato, T.; Hideshima, C.; Tashiro, M. A Convenient Preparation and Inclusion Behaviour of 1,3,5-Tris-(Hydroxyphenyl)-benzenes. Chem. Express 1990, 5, 845-848.
14. Bemis, G. W.; Murcko, M. A. The Properties of Known Drugs. 1. Molecular Frameworks. J. Med. Chem. 1996, 39, 2887-2893.
15. Caron, P. R.; Mullican, M. D.; Mashal, R. D.; Wilson, K. P.; Su, M. S.; Murcko, M. A. Chemogenomic Approaches to Drug Discovery. Curr. Opin. Chem. Biol. 2001, 5, 464-470.
16. Sadowski, J.; Gasteiger, J.; Klebe, G. Comparison of Automatic Three-Dimensional Model Builders Using 639 X-ray Crystal Structures. J. Chem. Inf. Comput. Sci. 1994, 34, 1000-1008.
17. Gasteiger, J.; Marsili, M. Iterative Partial Equalization of Orbital Electronegativity: A Rapid Access to Atomic Charges. Tetrahedron 1980, 36, 3219-3288.
18. Sybyl 6.7; Tripos Inc.: St. Louis, MO, 2000.
19. Sybyl Atom Types: http://tripos.com/custResources/mol2Files/ atom_types.html.
20. Brown, R. D.; Martin, Y. C. Use of Structure-Activity Data To Compare Structure-Based Clustering Methods and Descriptors for Use in Compound Selection. J. Chem. Inf. Comput. Sci. 1996, 36, 572-584.
21. Horvath, D. High Throughput Conformational Sampling and Fuzzy Similarity Metrics: A Novel Approach to Similarity Searching and Focused Combinatorial Library Design and Its Role in the Drug Discovery Laboratory. In Combinatorial Library Design and Evaluation: Principles, Software Tools and Applications; Ghose, A., Viswanadhan, V., Eds.; Marcel Dekker: New York, 2001; pp 429-472.
22. Mestres, J.; Rohrer, D. C.; Maggiora, G. M. MIMIC: A Molecular Field-Based Similarity Program. Exploiting the Applicability of Molecular Similarity Approaches. J. Comput. Chem. 1997, 18, 934-954.
23. Mestres, J.; Knegtel, R. M. A. Similarity versus Docking in 3D Virtual Screening. Perspect. Drug Discovery Des. 2000, 20, 191-207.
24. Shiau, A. K.; Barstad, D.; Loria, P. M.; Cheng, L.; Kushner, P. J.; Agard, D. A.; Greene, G. L. The Structural Basis of Estrogen Receptor/Coactivator Recognition and the Antagonism of This Interaction by Tamoxifen. Cell 1998, 95, 927-937.
25. Schoonen, W. E. G. J.; Dijkema, R.; de Ries, R. J. H.; Wagenaars, J. L.; Joosten, J. W. H.; de Gooyer, M. E.; Deckers, G. H.; Kloosterboer, H. J. Human Progesterone Receptor A and B Isoforms in CHO Cells II. Comparison of Binding, Transactivation and ED50 Values of Several Synthetic (Anti)progestagens in Vitro in CHO and MCF-7 Cells and in Vivo in Rats. J. Steroid Biochem. Mol. Biol. 1998, 64, 157-170.